ESBD_567618_1791985052712_Exhibit_K-2_Minnesota Infant Formula Issuance.xlsx

This is an infant formula issuance exhibit for the Texas WIC (Women, Infants, and Children) program documenting estimated formula distribution across six months from October 2025 through March 2026. The document provides detailed breakdown of powdered and ready-to-use formula issuances by product type, participant age groups (0-3 months, 4-5 months, and 6-11 months), and breastfeeding status (exclusively formula-fed and partially breastfed). The exhibit includes raw issuance data, redemption information from generic powder subcategories, and adjusted final quantities used for procurement planning. Major infant formula brands tracked include Similac Soy Isomil, Enfamil Reguline, Enfamil Gentlease, Enfamil Infant, Enfamil A.R., and Enfamil Neuropro variants in both powdered (12.4-13 ounces) and concentrate (13 ounces) formats, as well as ready-to-use 32-ounce containers. The exhibit also documents child-age formula issuances and includes a generic WIC-Allowed Formula powder category with substantial monthly quantities.

The document employs a methodology that combines direct formula issuances with redemption data from generic powder subcategories to generate comprehensive adjusted final estimates for procurement purposes. Monthly participant counts and benefit quantities are provided for each formula type across all demographic segments, enabling the state to estimate total demand and structure contracts accordingly. Six-month averages are calculated for each formula category to support rebate negotiations and vendor planning. The data indicates significant seasonal variation in issuance volumes, with quantities generally increasing from October through January before declining in February and March, reflecting typical WIC enrollment and participation patterns throughout the program year.